RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.
Source: investorplace.com
Stay updated with breaking news from What Merck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.
(Article by Matt Taibbi republished from Taibbi.Substack.com) Yesterday, I ran a story that had nothing to do with vaccines, about the seeming delay of the development of a drug called [...]
The best uncensored news, information, and analysis.